Kestutis M.
- Country
- Lithuania
- Department
- Pulmonology clinic
Research Overview
- A 52-week, randomised, double blind, multicentre, 2-arm parallel group trial assessing the efficacy and safety of CHF6001 (total daily dose 3200 μg) Dry Powder Inhaler (DPI) add-on to maintenance medium or high dose inhaled corticosteroid in combination with long-acting ß2-agonists in subjects with uncontrolled asthma
- Efficacy and Safety of Oral Dexpramipexole in Adolescents and Adults with Severe Eosinophilic Asthma: A Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Cystic Fibrosis Patients with 3849+10 Kb C->T Mutation
Data & Insights
Has run more than one trial at 86 of 379 partner sites.
Specializations
Respiratory Disorders
This investigator specializes in treating severe respiratory conditions, with particular emphasis on asthma management and its various manifestations. Their research encompasses both standard asthma cases and more complex presentations like severe eosinophilic asthma.
- Asthma Control Optimization
- Exacerbation Prevention
- Maintenance Therapy Advancement
They focus on evaluating innovative therapeutic approaches for patients whose conditions remain uncontrolled on standard treatments.
Genetic Respiratory Conditions
The investigator demonstrates significant expertise in treating cystic fibrosis, exploring new therapeutic interventions through inhalation-based treatments. Their work involves evaluating novel compounds for this challenging genetic condition.
- Inhaled Therapeutics
- Treatment Safety Assessment
- Drug Tolerability Studies
Their research encompasses comprehensive evaluation of new therapeutic agents for genetic respiratory disorders.
Therapeutic Innovation
The investigator's work extends to evaluating novel therapeutic compounds for respiratory conditions, including assessment of new drug formulations and delivery systems.
- Advanced Drug Development
- Therapeutic Safety Profiles
- Long-term Treatment Outcomes
Their research focuses on establishing the efficacy and safety of innovative respiratory medications across extended treatment periods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.